743004646	743004646	CD	B-NP	O
|	|	NN	I-NP	O
DCH	DCH	NN	I-NP	O
|	|	NN	I-NP	O
20339937	20339937	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4076800	4076800	CD	B-NP	O
|	|	CC	I-NP	O
7/6/2006	7/6/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/2/2006	6/2/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/5/2006	2/5/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
FUGATE	FUGATE	NNP	B-NP	O
,	,	,	O	O
TIM	TIM	NNP	B-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Lewter	Lewter	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Tci	Tci	NNP	B-NP	O
Prosamp	Prosamp	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
5/23/06	5/23/06	CD	B-NP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
intermittent	intermittent	JJ	B-NP	O
left-sided	left-sided	JJ	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
each	each	DT	B-NP	O
episode	episode	NN	I-NP	O
lasting	last	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
10	10	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
incomplete	incomplete	JJ	I-NP	O
left	left	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
downsloping	downslope	VBG	B-VP	O
1-1	1-1	CD	B-NP	O
.5	.5	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V3	V3	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
aVL	aVL	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	B-protein
and	and	CC	I-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
heparinized	heparinize	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/26/06	11/26/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ostial	ostial	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mid	mid	JJ	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mid	mid	JJ	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
dominant	dominant	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
collateral	collateral	NN	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
diagonal	diagonal	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
marginal	marginal	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
branch	branch	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
marginal	marginal	JJ	I-NP	O
,	,	,	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
apical	apical	JJ	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
AND	AND	NNP	I-NP	O
SURGICAL	SURGICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
87	87	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
0.48	0.48	CD	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
IV	IV	CD	I-NP	O
angina	angina	NN	I-NP	O
with	with	IN	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
carry	carry	VB	I-VP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
physical	physical	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
class	class	NN	B-NP	O
II	II	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
limitation	limitation	NN	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
fem-pop	fem-pop	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
and	and	CC	I-NP	O
status	status	NN	I-NP	O
post	post	VBP	B-VP	O
bilateral	bilateral	JJ	B-NP	O
transmetatarsal	transmetatarsal	JJ	I-NP	O
amputations	amputation	NNS	I-NP	O
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
eosinophilia	eosinophilia	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	VBP	B-VP	O
TIME	TIME	NN	B-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Lopressor	Lopressor	NN	B-NP	O
37.5	37.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
meclizine	meclizine	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
,	,	,	O	O
Niaspan	Niaspan	NNP	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
,	,	,	O	O
Zincate	Zincate	NNP	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NNP	B-NP	O
for	for	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
lifts	lift	NNS	I-NP	O
or	or	CC	I-NP	O
heaves	heave	NNS	I-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	B-protein
vascular	vascular	JJ	I-NP	I-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
carotid	carotid	NN	I-NP	O
,	,	,	O	O
radial	radial	NN	B-NP	O
,	,	,	O	O
femoral	femoral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
:	:	:	O	O
Breath	Breath	NNP	B-NP	O
sounds	sound	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Allen	Allen	NNP	B-NP	O
's	's	POS	B-NP	O
test	test	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
abnormal	abnormal	JJ	B-NP	O
intermittent	intermittent	JJ	I-NP	O
waveform	waveform	NN	I-NP	O
with	with	IN	B-PP	O
radial	radial	JJ	B-NP	O
occluded	occlude	VBN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
oximeter	oximeter	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
abnormal	abnormal	JJ	I-NP	O
poor	poor	JJ	I-NP	O
intermittent	intermittent	JJ	I-NP	O
wave	wave	NN	I-NP	O
form	form	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
radial	radial	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
oximeter	oximeter	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
is	be	VBZ	B-VP	O
noncontributory	noncontributory	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
128	128	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
21	21	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
201	201	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
5.81	5.81	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
28.6	28.6	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
10.2	10.2	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
132	132	CD	B-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	O
of	of	IN	B-PP	O
18.2	18.2	CD	B-NP	O
,	,	,	O	O
PT/INR	PT/INR	NN	B-NP	B-protein
1.5	1.5	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	O
of	of	IN	B-PP	O
33.7	33.7	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Jana	Jana	NNP	I-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
3/26/06	3/26/06	CD	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
anterior	anterior	RB	B-ADVP	O
descending	descend	VBG	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sequential	sequential	JJ	I-NP	O
graft	graft	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
connecting	connect	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
branch	branch	NN	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
55	55	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
crossclamp	crossclamp	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
46	46	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
intraoperatively	intraoperatively	RB	I-ADVP	O
,	,	,	O	O
came	come	VBD	B-VP	O
off	off	RP	B-PRT	O
bypass	bypass	NN	B-NP	O
without	without	IN	B-PP	O
incident	incident	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CK-MB	CK-MB	NN	I-NP	B-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
EKG	EKG	NNP	B-NP	O
normalized	normalize	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
postop	postop	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
moderate-to-severe	moderate-to-severe	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
venous	venous	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
bibasally	bibasally	RB	B-VP	O
requiring	require	VBG	I-VP	O
vigorous	vigorous	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
toilet	toilet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Mellitus	Mellitus	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
non-insulin-dependent	non-insulin-dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
medication	medication	NN	I-NP	O
of	of	IN	B-PP	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
postoperatively	postoperatively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
re-started	re-starte	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
as	as	RB	B-ADVP	O
low	low	JJ	I-ADVP	O
as	as	IN	B-PP	O
59	59	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
HIT	HIT	NN	I-NP	B-protein
panel	panel	NN	I-NP	I-protein
sent	send	VBD	B-VP	I-protein
off	off	RP	B-PRT	I-protein
which	which	WDT	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
trended	trend	VBD	B-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
143	143	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Gier	Gier	NNP	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Step-Down	Step-Down	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
pacing	pacing	NN	I-NP	O
wires	wire	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
for	for	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
Foley	Foley	NNP	B-NP	O
reinsertion	reinsertion	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
failed	fail	VBD	B-VP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
voiding	voiding	NN	I-NP	O
trial	trial	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
leg	leg	NN	I-NP	O
bag	bag	NN	I-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Urology	Urology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Flomax	Flomax	NN	I-NP	O
until	until	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
labs	lab	NNS	I-NP	O
for	for	IN	B-PP	O
Mr.	Mr.	NNP	B-NP	O
Howlingwolf	Howlingwolf	NNP	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
8.6	8.6	CD	I-NP	I-cell_line
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
11	11	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
31.4	31.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
143	143	CD	B-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	O
of	of	IN	B-PP	O
17.1	17.1	NN	B-NP	B-protein
,	,	,	O	O
PT/INR	PT/INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
from	from	IN	B-PP	O
6/2/06	6/2/06	CD	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
so	so	RB	B-ADVP	O
far	far	RB	I-ADVP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NNP	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
while	while	IN	B-SBAR	O
taking	take	VBG	B-VP	O
Dilaudid	Dilaudid	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
2-4	2-4	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NNP	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
QD	QD	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
QD	QD	NN	I-NP	O
per	per	IN	B-PP	O
INR	INR	NN	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
receive	receive	VB	I-VP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
this	this	DT	B-NP	O
evening	evening	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kurt	Kurt	NNP	I-NP	O
Goodwill	Goodwill	NNP	I-NP	O
at	at	IN	B-PP	O
-LRB-	-LRB-	NNP	B-NP	O
644	644	CD	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
227-4267	227-4267	CD	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
PLANS	PLANS	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bert	Bert	NNP	I-NP	O
Levering	Levering	NNP	I-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Reuben	Reuben	NNP	I-NP	O
Duttinger	Duttinger	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	B-NP	O
Wilton	Wilton	NNP	I-NP	O
Durkee	Durkee	NNP	I-NP	O
on	on	IN	B-PP	O
2/6/06	2/6/06	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Urology	Urology	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Centsson	Centsson	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Clinic	Clinic	JJ	B-NP	O
number	number	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
429	429	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
408-6176	408-6176	CD	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Fagin	Fagin	NNP	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-1529941	2-1529941	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ARROWOOD	ARROWOOD	NN	B-NP	O
,	,	,	O	O
TIM	TIM	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ARRANTS	ARRANTS	NNP	B-NP	O
,	,	,	O	O
CLIFTON	CLIFTON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9727509	9727509	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/19/06	11/19/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/19/06	11/19/06	CD	B-NP	O

